Compare Medpace Holdings Inc (MEDP) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs SkyWest Inc — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while SkyWest Inc trades at $96.52 (market cap $3.75B). The key difference: Medpace Holdings Inc is far larger — about 4.5× SkyWest Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and SkyWest Inc for 8 Days on average.
| MEDP | SKYW | |
|---|---|---|
Market Cap | $16.82B | $3.75B |
Volume | 223,093 | 196,324 |
Sector | Health | Industrials |
52-Week High | $630.19 | $115.94 |
52-Week Low | $393.42 | $78.40 |
Typical Hold Time | 14 Days | 8 Days |
Enterprise Value | $16.44B | $5.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
SkyWest (SKYW) trades at $96.52, down 0.12% with a bearish technical signal despite strong analyst support. The stock shows mixed earnings performance with Q1 2026 beating expectations but Q4 2025 and Q2 2026 missing estimates. Fundamentally, the company maintains solid profitability with 9.78% net margin and attractive valuation metrics including a P/E of 9.6. Recent news highlights fleet modernization efforts and expanding flying agreements while executives have been selling shares.
The outlook remains cautiously optimistic with a $112 consensus price target representing 16% upside potential. Key opportunities include fleet expansion and strong cash flow generation, while risks involve cost pressures and recent insider selling activity. The stock presents a value opportunity given its below-market valuation multiples and positive analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
